Kaufman v. Cooper Companies, Inc.

719 F. Supp. 174, 1989 WL 87751
CourtDistrict Court, S.D. New York
DecidedAugust 3, 1989
Docket89 Civ. 4856 (DNE), 89 Civ. 4867 (DNE)
StatusPublished
Cited by9 cases

This text of 719 F. Supp. 174 (Kaufman v. Cooper Companies, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kaufman v. Cooper Companies, Inc., 719 F. Supp. 174, 1989 WL 87751 (S.D.N.Y. 1989).

Opinion

OPINION & ORDER

EDELSTEIN, District Judge:

BACKGROUND

This litigation arises out of a protracted battle for control of The Cooper Companies, Inc. (“TCC”). TCC is a Delaware corporation with its principal place of business in Palo Alto, California whose shares are publicly traded on the New York and Pacific Stock Exchanges. Until recently, it was engaged in various health care related businesses. In May of 1988, amid financial pressures, it began a divestiture of most of its operating business. As a result of this divestiture, the Company has amassed sub *177 stantial cash holdings and must now decide how to invest this cash.

In 1958, Parker G. Montgomery, a party to this litigation, founded Cooper Laboratories, Inc. (“Cooper Labs”). In 1983, Cooper Labs was liquidated and CooperVision, Inc., which later changed its name to TCC, was formed. Two other companies, Cooper Development Corporation (“CDC”) and Cooper Life Sciences (“CLS”), were also spun off as separate corporations to Cooper Labs shareholders following the divestiture. Montgomery, who was Chairman of the Board and Chief Executive Officer of Cooper Labs, remained as Chairman of CDC, CLS, and Chief Executive of TCC. In 1988, Montgomery also assumed the Chief Executive position of CDC and CLS.

In early 1988, two sets of brothers, Howard, Wayne, and Bruce Sturman (the “Sturmans”) and Steven, Brad, and Gary Singer (the “Singers”), acquired a significant block of TCC common stock. In order to avoid a proxy fight, Montgomery consented to Steven Singer and the Sturmans becoming directors in May of 1988. In July of 1988, Montgomery stepped down as Chairman and Chief Executive officer, the remaining Singer brothers were elected to the Board, and Gary A. Singer became Co-Chairman and Co-Chief Executive with Howard Sturman. In October of 1988, Montgomery relinquished his remaining positions with TCC as director and officer.

In addition to Common Stock, TCC has outstanding Preferred Stock and 10-%% Convertible Subordinated Reset Debentures due 2005 (“Debentures”). CDC and CLS, which are Delaware corporations, together own 100% of the outstanding Preferred Stock. These corporations have virtually no current operating businesses. Their main assets are the shares of TCC Preferred Stock.

Between October 31, 1988 and April 30, 1989, shareholder equity in TCC has decreased by approximately $30 million and the company has incurred a net loss applicable to Common Stock of approximately $44 million. In addition, CDC and CLS, through Montgomery, negotiated with TCC during most of 1989 to change the status of the preferred shareholders. Montgomery sought to surrender some of the preferred status of the CDC and CLS in exchange for the participation in profits and voting power that accompanies the ownership of Common Stock. The dispute between CDC and CLS on the one hand, and TCC on the other, centered on a dispute over how much CDC owed TCC and viceversa as a result of certain loans made while the companies were in related businesses. These negotiations proved unsuccessful because TCC declined to repurchase the Preferred Stock.

One of the last major portions of its business that TCC agreed to sell was its Cooper Technicon, Inc. (“CTI”) division to Miles Inc. for $212 million. One of the conditions of closing on that deal was the obtaining of consents from all the shareholders, including the holders of Preferred Stock. By agreement dated October 21, 1988, CDC and CLS eventually gave its consent to the sale of CTI in their capacity as holders of the Preferred Stock. Nevertheless, on March 21, 1989, Montgomery sent a letter on behalf of CDC and CLS purporting to revoke the previously given consents on the ground that certain representations regarding the redemption or repurchase of Preferred Stock had not been honored. A lawsuit in Delaware (“Delaware Litigation”) ensued that resulted in a judgment, dated June 15, 1989, declaring the original consents to be valid, enforceable, and irrevocable. On June 22, 1989, the consent of the Common Stockholders was obtained and the sale of CTI was consummated one week later, on June 29, 1989. After the sale of CTI, TCC was left with virtually no operating assets and a substantial amount of cash.

On June 29, 1989, the defendants in the Cooper Action, 89 Civ. 4867 (DNE) formed The Cooper Companies Stockholders’ Committee (the “Stockholders’ Committee” or the “Committee” or the “Marx Group”). The Committee’s goal was to wage a proxy contest for the election of directors at the upcoming Annual Meeting of TCC, scheduled for August 2, 1989. On July 5, 1989, the Committee filed a Proxy Statement *178 with the Securities Exchange Commission (the “Commission” or “SEC”) and issued certain statements to the press through one of the members of the Committee, Theodore H. Kruttschnitt. The Committee proposed its own slate of directors that includes Marx and Kruttschnitt, but does not include Montgomery. On July 6, 1989, TCC management filed its own proxy statement and Notice of Annual Meeting to stockholders.

On July 17, 1989, the instant actions were filed. The plaintiffs in the Kaufman Action, 89 Civ. 4856 (DNE) are three holders of TCC Common Stock. Moses Marx is the largest individual shareholder in TCC, owning approximately 7.0% of the outstanding shares. 1 Marx and Mel Schnell are also members of the Stockholders’ Committee. The defendants are TCC and the management nominees for the Board, with the exception of Frederick J. Adler. The plaintiffs in the Cooper Action, 89 Civ. 4867 (DNE) are TCC and Bruce Sturman, a TCC director. The defendants are the participants in the Stockholders’ Committee proxy solicitation.

Both parties moved for preliminary injunction. By stipulation and order the parties agreed to participate in expedited discovery and expedited briefing schedule so that the motion could be heard before the August 2, 1989 meeting. On July 27,1989, the court heard oral argument on the cross-motions for preliminary injunction. 2

DISCUSSION

In this circuit, a party seeking a preliminary injunction must demonstrate irreparable injury, and either (1) likelihood of success on the merits or (2) sufficiently serious questions going to the merits to make them a fair ground for litigation and a balance of hardships tipping decidedly in favor of the party seeking the seeking the injunction. See Abdul Wali v. Coughlin, 754 F.2d 1015, 1025-26 (2d Cir.1985).

I. Irreparable Injury

Both parties to this litigation concur that violations of the Proxy Rules 3 may cause irreparable injury supporting injunctive relief. Federal courts are empowered to “grant all necessary remedial relief” to effectuate the purposes behind Section 14(a) of the Securities Exchange Act. J.I. Case v. Borak, 377 U.S. 426, 435, 84 S.Ct. 1555, 1561, 12 L.Ed.2d 423 (1964). By the terms of Section 14(a), violations of the rules promulgated under that section are deemed violations of the Securities Exchange Act. See Ash v. GAF Corp.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
719 F. Supp. 174, 1989 WL 87751, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kaufman-v-cooper-companies-inc-nysd-1989.